Finally, the translation of the EMT-associated transcriptomic profile to HNSCC patient cohorts showed prognostic value and confirmation of therapeutically exploitable EGFR-related vulnerabilities. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.